These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7524044)

  • 1. Use of in vitro and in vivo data in the design, development, and quality control of sustained-release decongestant dosage forms.
    Brock MH; Dansereau RJ; Patel VS
    Pharmacotherapy; 1994; 14(4):430-7. PubMed ID: 7524044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules.
    Ishida M; Abe K; Hashizume M; Kawamura M
    Int J Pharm; 2008 Jul; 359(1-2):46-52. PubMed ID: 18467046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of commercially available meth-deterrent pseudoephedrine hydrochloride products.
    Rahman Z; Aqueel MS; Korang-Yeboah M; Zidan AS; Chen J; Alayoubi AY; Cruz CN; Ashraf M
    Int J Pharm; 2020 Feb; 575():118909. PubMed ID: 31811923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of terfenadine-pseudoephedrine double-layer tablet dissolution-equivalent to core tablet.
    Choi HG; Yong C; Kim CK
    Drug Dev Ind Pharm; 2000 Jun; 26(6):605-11. PubMed ID: 10826108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of near zero-order release dosage forms using three-dimensional printing (3-DP) technology.
    Wang CC; Tejwani Motwani MR; Roach WJ; Kay JL; Yoo J; Surprenant HL; Monkhouse DC; Pryor TJ
    Drug Dev Ind Pharm; 2006 Mar; 32(3):367-76. PubMed ID: 16556541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of pseudoephedrine from controlled release formulations in the presence of guaifenesin in human volunteers.
    Pade V; Aluri J; Manning L; Stavchansky S
    Biopharm Drug Dispos; 1995 Jul; 16(5):381-91. PubMed ID: 8527687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus xylometazoline nasal spray in nasal congestion.
    Stübner UP; Toth J; Marks B; Berger UE; Burtin B; Horak F
    Arzneimittelforschung; 2001 Nov; 51(11):904-10. PubMed ID: 11765592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo evaluation of a once-daily controlled-release pseudoephedrine product.
    Hwang SS; Gorsline J; Louie J; Dye D; Guinta D; Hamel L
    J Clin Pharmacol; 1995 Mar; 35(3):259-67. PubMed ID: 7608314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
    Pleskow W; Grubbe R; Weiss S; Lutsky B
    Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Drug Properties and Formulation on In Vitro Drug Release and Biowaiver Regulation of Oral Extended Release Dosage Forms.
    Lin Z; Zhou D; Hoag S; Qiu Y
    AAPS J; 2016 Mar; 18(2):333-45. PubMed ID: 26769249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopharmaceutical characterization of sustained release matrix tablets based on novel carbomer polymers: formulation and in vivo investigation.
    Jelena P; Djurić Z; Jovanović M; Ibrić S; Kilibarda V; Jovanović D; Evic IK
    Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):99-104. PubMed ID: 16010868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudoephedrine and circadian rhythm interaction on neuromuscular performance.
    Pallarés JG; López-Samanes Á; Fernández-Elías VE; Aguado-Jiménez R; Ortega JF; Gómez C; Ventura R; Segura J; Mora-Rodríguez R
    Scand J Med Sci Sports; 2015 Dec; 25(6):e603-12. PubMed ID: 25515692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, parallel-group, multicenter, placebo-controlled study of the safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for symptom relief as an adjunctive therapy to antibiotic treatment of acute respiratory infections.
    LaForce C; Gentile DA; Skoner DP
    Postgrad Med; 2008 Jul; 120(2):53-9. PubMed ID: 18654069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between dissolution in vitro and absorption in vivo of chuanping sustained release tablets].
    Cai YQ; Zhang ZP; Wu YH; Liu J; Xie JF; Chai JZ; Luo Y; Zhu SS
    Zhongguo Zhong Yao Za Zhi; 2013 Oct; 38(20):3473-8. PubMed ID: 24490556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A canine biorelevant dissolution method for predicting in vivo performance of orally administered sustained release matrix tablets.
    Walsh PL; Bothe JR; Bhardwaj S; Hu M; Nofsinger R; Xia B; Persak S; Pennington J; Bak A
    Drug Dev Ind Pharm; 2016; 42(5):836-44. PubMed ID: 26339722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual release and molecular mechanism of bilayered aceclofenac tablet using polymer mixture.
    Van Nguyen H; Nguyen VH; Lee BJ
    Int J Pharm; 2016 Dec; 515(1-2):233-244. PubMed ID: 27744034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.